Akihiko Takashima

15.9k total citations · 1 hit paper
195 papers, 12.4k citations indexed

About

Akihiko Takashima is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Akihiko Takashima has authored 195 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Physiology, 99 papers in Molecular Biology and 65 papers in Cellular and Molecular Neuroscience. Recurrent topics in Akihiko Takashima's work include Alzheimer's disease research and treatments (138 papers), Neuroscience and Neuropharmacology Research (45 papers) and Cholinesterase and Neurodegenerative Diseases (38 papers). Akihiko Takashima is often cited by papers focused on Alzheimer's disease research and treatments (138 papers), Neuroscience and Neuropharmacology Research (45 papers) and Cholinesterase and Neurodegenerative Diseases (38 papers). Akihiko Takashima collaborates with scholars based in Japan, United States and Portugal. Akihiko Takashima's co-authors include Miyuki Murayama, Yuji Yoshiike, Naruhiko Sahara, Kazutomo Imahori, Sumihiro Maeda, Ohoshi Murayama, Kentaro Tanemura, Masahito Yamada, Kenjiro Ono and Koichi Ishiguro and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Akihiko Takashima

191 papers receiving 12.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of Concern: Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

2003 587 citations Akihiko Takashima et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akihiko Takashima Japan	61	7.5k	5.8k	3.1k	2.1k	1.6k	195	12.4k
Gunnar K. Gouras Sweden	46	7.1k 0.9×	4.1k 0.7×	3.0k 1.0×	2.0k 0.9×	1.3k 0.8×	106	10.5k
Christopher B. Eckman United States	50	9.3k 1.2×	5.9k 1.0×	2.3k 0.7×	2.4k 1.2×	1.2k 0.8×	78	12.6k
Nobuhisa Iwata Japan	50	6.8k 0.9×	4.4k 0.8×	2.9k 0.9×	1.8k 0.9×	1.2k 0.7×	142	11.6k
Cheng‐Xin Gong United States	70	9.5k 1.3×	7.5k 1.3×	3.3k 1.1×	2.4k 1.1×	1.8k 1.1×	170	16.0k
Marc Mercken Belgium	44	7.9k 1.1×	4.3k 0.7×	2.3k 0.7×	1.9k 0.9×	1.3k 0.8×	102	10.8k
Paul M. Mathews United States	53	7.5k 1.0×	4.5k 0.8×	2.0k 0.6×	1.5k 0.7×	1.6k 1.0×	106	11.3k
Frédéric Checler France	69	8.6k 1.2×	8.0k 1.4×	4.8k 1.5×	2.5k 1.2×	1.9k 1.2×	267	15.7k
Yadong Huang United States	63	6.9k 0.9×	5.3k 0.9×	2.7k 0.9×	1.5k 0.7×	686 0.4×	143	13.9k
Jochen Walter Germany	60	6.0k 0.8×	5.3k 0.9×	2.3k 0.7×	1.5k 0.7×	1.6k 1.0×	148	11.6k
Mikio Shoji Japan	55	7.0k 0.9×	5.5k 0.9×	2.7k 0.8×	1.4k 0.7×	931 0.6×	293	12.0k

Countries citing papers authored by Akihiko Takashima

Since Specialization

Citations

This map shows the geographic impact of Akihiko Takashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiko Takashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiko Takashima more than expected).

Fields of papers citing papers by Akihiko Takashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiko Takashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiko Takashima. The network helps show where Akihiko Takashima may publish in the future.

Co-authorship network of co-authors of Akihiko Takashima

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiko Takashima. A scholar is included among the top collaborators of Akihiko Takashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiko Takashima. Akihiko Takashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Toru, Sachiyo Ohashi, Akihiko Takashima, & Shunsuke Kobayashi. (2024). Effect of calcium ions on the aggregation of highly phosphorylated tau. Biochemistry and Biophysics Reports. 40. 101887–101887.

Bannai, Hiroko, Akihiko Takashima, Yoshiyuki Soeda, et al.. (2024). Research on the molecular mechanism of singularity phenomenon in neurological disorders. Biophysics and Physicobiology. 21(Supplemental). n/a–n/a. 1 indexed citations

Hanyu, Haruo, et al.. (2024). Path Integration Detects Prodromal Alzheimer’s Disease and Predicts Cognitive Decline. Journal of Alzheimer s Disease. 101(2). 651–660. 1 indexed citations

Morino, Hiroyuki, Takashi Kurashige, Yukiko Matsuda, et al.. (2024). Clinical and Pathological Features of FTDP ‐17 with MAPT p.K298_H299insQ Mutation. Movement Disorders Clinical Practice. 11(6). 720–727. 2 indexed citations

Soeda, Yoshiyuki, Atsushi Kasai, Yusuke Fujioka, et al.. (2023). Path integration deficits are associated with phosphorylated tau accumulation in the entorhinal cortex. Brain Communications. 6(1). fcad359–fcad359. 4 indexed citations

Saito, Taro, Satoko Wada‐Kakuda, Saori Abe, et al.. (2021). Disulfide bond formation in microtubule-associated tau protein promotes tau accumulation and toxicity in vivo. Human Molecular Genetics. 30(21). 1955–1967. 29 indexed citations

Yu, Xiu‐Jun, Yoshiki Matsuda, Nobuyuki Ozawa, et al.. (2021). Essential roles of plexin-B3+ oligodendrocyte precursor cells in the pathogenesis of Alzheimer’s disease. Communications Biology. 4(1). 870–870. 14 indexed citations

Soeda, Yoshiyuki, et al.. (2021). Memory formation in old age requires GSK-3β. SHILAP Revista de lepidopterología. 1. 100022–100022. 2 indexed citations

Ano, Yasuhisa, Rena Ohya, T. Yamazaki, et al.. (2020). Hop bitter acids containing a β-carbonyl moiety prevent inflammation-induced cognitive decline via the vagus nerve and noradrenergic system. Scientific Reports. 10(1). 20028–20028. 9 indexed citations

10.

Ano, Yasuhisa, et al.. (2020). β-Lactolin, a Whey-Derived Lacto-Tetrapeptide, Prevents Alzheimer’s Disease Pathologies and Cognitive Decline. Journal of Alzheimer s Disease. 73(4). 1331–1342. 23 indexed citations

11.

Nakamura, Mari, Seiji Shiozawa, Daisuke Tsuboi, et al.. (2019). Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs. Stem Cell Reports. 13(4). 684–699. 45 indexed citations

12.

Ano, Yasuhisa, Misato Yoshikawa, Makoto Michikawa, et al.. (2019). Iso-α-Acids, Bitter Components in Beer, Suppress Inflammatory Responses and Attenuate Neural Hyperactivation in the Hippocampus. Frontiers in Pharmacology. 10. 81–81. 11 indexed citations

13.

Kobayashi, Shunsuke, Toru Tanaka, Yoshiyuki Soeda, Osborne F. X. Almeida, & Akihiko Takashima. (2017). Local Somatodendritic Translation and Hyperphosphorylation of Tau Protein Triggered by AMPA and NMDA Receptor Stimulation. EBioMedicine. 20. 120–126. 56 indexed citations

14.

Moreira, Pedro Silva, Ioannis Sotiropoulos, Joana Silva, et al.. (2016). The Advantages of Structural Equation Modeling to Address the Complexity of Spatial Reference Learning. Frontiers in Behavioral Neuroscience. 10. 18–18. 10 indexed citations

15.

Iohara, Koichiro, Masanori Fujita, Yoshiko Ariji, et al.. (2016). Assessment of Pulp Regeneration Induced by Stem Cell Therapy by Magnetic Resonance Imaging. Journal of Endodontics. 42(3). 397–401. 40 indexed citations

16.

Li, Yang, et al.. (2010). Convergence of Presenilin- and Tau-Mediated Pathways on Axonal Trafficking and Neuronal Function. Journal of Neuroscience. 30(40). 13409–13418. 26 indexed citations

17.

Marambaud, Philippe, Paul H. Wen, Junichi Shioi, et al.. (2003). A CBP Binding Transcriptional Repressor Produced by the PS1/ϵ-Cleavage of N-Cadherin Is Inhibited by PS1 FAD Mutations. Cell. 114(5). 635–645. 400 indexed citations

18.

Katayama, Taiichi, Kazunori Imaizumi, Naoya Sato, et al.. (1999). Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nature Cell Biology. 1(8). 479–485. 449 indexed citations

19.

Takashima, Akihiko & J G Kenimer. (1993). Regulation of muscarinic stimulation of norepinephrine release and PI hydrolysis during cell growth in PC12 cells. Neuroscience Letters. 153(1). 77–79. 4 indexed citations

20.

Takashima, Akihiko. (1993). Tau protein I is essential for amyloid β-protein iduced neurotoxicity. Proc Natl Acad Sci USA. 90. 7789–7793. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact